Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Autoimmune Disorders

Free Subscription 28.06.2021 4 BMC Neurol 1 Brain 1 Diabetes 6 Intern Med 2 J Autoimmun 1 J Clin Endocrinol Metab 3 J Immunol 1 J Neuroimmunol 20 J Neurol 1 J Pediatr Endocrinol Metab 10 Kidney Int 5 Lancet Neurol 2 Mult Scler 1 N Engl J Med 1 Nat Rev Neurol 2 PLoS One 2 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. NEDEL BL, Duarte JA, Gerchman F
   MRI-based early diagnosis: a diabetic Charcot spine case report.
   BMC Neurol. 2021;21:202.
   PubMed         Abstract available
   
   
2. MAGHBOOLI Z, Naser Moghadasi A, Rezaeimanesh N, Omidifar A, et al
   The possible role of Interleukin-6 as a regulator of insulin sensitivity in patients with neuromyelitis optica spectrum disorder.
   BMC Neurol. 2021;21:167.
   PubMed         Abstract available
   
   
3. D'HOOGHE M, Willekens B, Delvaux V, D'haeseleer M, et al
   Sativex(R) (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience.
   BMC Neurol. 2021;21:227.
   PubMed         Abstract available
   
   
4. BUTRYN M, Mewes S, Feist E, Beuing O, et al
   Tocilizumab-associated posterior reversible encephalopathy syndrome in giant-cell arteritis - case report.
   BMC Neurol. 2021;21:228.
   PubMed         Abstract available
   
   

   
   Brain

5. PELLERIN K, Rubino SJ, Burns JC, Smith BA, et al
   MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative response.
   Brain. 2021 Jun 18. pii: 6305830. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Diabetes

6. LERNMARK A
   Etiology of Autoimmune Islet Disease: Timing Is Everything.
   Diabetes. 2021 Jun 21. pii: dbi18-0034. doi: 10.2337/dbi18-0034.
   PubMed         Abstract available
   
   

   
   Intern Med

7. YOSHIDA H, Takahashi N, Horiguchi T, Yasuhara H, et al
   Development of Myeloperoxidase Anti-neutrophil Cytoplasmic Antibody-positive Necrotizing Crescentic Glomerulonephritis in an Elderly Patient with Immunological Kidney Disease.
   Intern Med. 2021 Jun 19. doi: 10.2169/internalmedicine.7252.
   PubMed         Abstract available
   
   
8. MUTOH Y, Kano Y, Oguri T, Kato H, et al
   Severe Measles Encephalitis and Acute Disseminated Encephalomyelitis in an Immunocompetent Japanese Young Male.
   Intern Med. 2021;60:1971-1976.
   PubMed         Abstract available
   
   
9. KAWAZOE T, Inoue T, Tobisawa S, Sugaya K, et al
   Immunoglobulin G4-related Disease Accompanied by Peripheral Neuropathy: A Report of Two Cases.
   Intern Med. 2021;60:1941-1947.
   PubMed         Abstract available
   
   
10. MUSHINO T, Hiroi T, Yamashita Y, Suzaki N, et al
    Progressive Massive Splenomegaly in an Adult Patient with Kabuki Syndrome Complicated with Immune Thrombocytopenic Purpura.
    Intern Med. 2021;60:1927-1933.
    PubMed         Abstract available
    
    
11. TANITAME K, Araki M, Kunishige T
    Peripheral Nerve Enlargement in Chronic Inflammatory Demyelinating Polyneuropathy.
    Intern Med. 2021;60:1801-1802.
    PubMed        
    
    
12. ENDO N, Shimizu H, Tanaka T, Nakase Y, et al
    Rapidly Progressive Kidney Failure Associated with Perirenal Capsular Lesion Due to IgG4-Related Disease.
    Intern Med. 2021;60:1893-1897.
    PubMed         Abstract available
    
    

    
    J Autoimmun

13. RODRIGUEZ-PEREZ AI, Labandeira CM, Pedrosa MA, Valenzuela R, et al
    Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19.
    J Autoimmun. 2021;122:102683.
    PubMed         Abstract available
    
    
14. DIANA T, Ungerer M, Wuster C, Fassbender J, et al
    A cyclic peptide significantly improves thyroid function, thyrotropin-receptor antibodies and orbital mucine /collagen content in a long-term Graves' disease mouse model.
    J Autoimmun. 2021;122:102666.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

15. LI CW, Sachidanandam R, Jayaprakash A, Yi Z, et al
    Identification Of New Rare Variants Associated With Familial Autoimmune Thyroid Diseases By Deep Sequencing Of Linked Loci.
    J Clin Endocrinol Metab. 2021 Jun 18. pii: 6304283. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Immunol

16. ZHANG J, Bouch RJ, Blekhman MG, He Z, et al
    USP19 Suppresses Th17-Driven Pathogenesis in Autoimmunity.
    J Immunol. 2021 Jun 16. pii: jimmunol.2100205. doi: 10.4049/jimmunol.2100205.
    PubMed         Abstract available
    
    
17. NEEDHAM EJ, Stoevesandt O, Thelin EP, Zetterberg H, et al
    Complex Autoantibody Responses Occur following Moderate to Severe Traumatic Brain Injury.
    J Immunol. 2021 Jun 18. pii: jimmunol.2001309. doi: 10.4049/jimmunol.2001309.
    PubMed         Abstract available
    
    
18. CHURCH ME, Ceja G, McGeehan M, Miller MC, et al
    Meningeal B Cell Clusters Correlate with Submeningeal Pathology in a Natural Model of Multiple Sclerosis.
    J Immunol. 2021 Jun 23. pii: jimmunol.2000514. doi: 10.4049/jimmunol.2000514.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

19. REYES S, Cunningham AL, Kalincik T, Havrdova EK, et al
    Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement.
    J Neuroimmunol. 2021;357:577627.
    PubMed         Abstract available
    
    

    
    J Neurol

20. VAN ROSMALEN MHJ, Goedee HS, van der Gijp A, Witkamp TD, et al
    Quantitative assessment of brachial plexus MRI for the diagnosis of chronic inflammatory neuropathies.
    J Neurol. 2021;268:978-988.
    PubMed         Abstract available
    
    
21. CHAUDHARY UJ, Rajabally YA
    Underdiagnosis and diagnostic delay in chronic inflammatory demyelinating polyneuropathy.
    J Neurol. 2021;268:1366-1373.
    PubMed         Abstract available
    
    
22. NETRAVATHI M, Holla VV, Nalini A, Yadav R, et al
    Myelin oligodendrocyte glycoprotein-antibody-associated disorder: a new inflammatory CNS demyelinating disorder.
    J Neurol. 2021;268:1419-1433.
    PubMed         Abstract available
    
    
23. MASUCCIO FG, Barra M, Claudio G, Claudio S, et al
    A rare case of acute motor axonal neuropathy and myelitis related to SARS-CoV-2 infection.
    J Neurol. 2021;268:2327-2330.
    PubMed         Abstract available
    
    
24. SCHROTER N, Weiller C, Rauer S, Waller CF, et al
    Anti-glycin-receptor antibody related stiff-person syndrome under treatment with an immune checkpoint inhibitor.
    J Neurol. 2021;268:709-711.
    PubMed        
    
    
25. MARTIN T, Duke S, Kumar V, Fadhil A, et al
    NMDAR antibody encephalitis overlapping with CLIPPERS syndrome in a psoriasis patient on adalimumab.
    J Neurol. 2021;268:714-716.
    PubMed        
    
    
26. OKADA K, Seki M, Yaguchi H, Sakuta K, et al
    Polyradiculoneuropathy induced by immune checkpoint inhibitors: a case series and review of the literature.
    J Neurol. 2021;268:680-688.
    PubMed         Abstract available
    
    
27. KASS-ILIYYA L, Snowden JA, Thorpe A, Jessop H, et al
    Autologous haematopoietic stem cell transplantation for refractory stiff-person syndrome: the UK experience.
    J Neurol. 2021;268:265-275.
    PubMed         Abstract available
    
    
28. STOECKLEIN VM, Kellert L, Patzig M, Kupper C, et al
    Extended stereotactic brain biopsy in suspected primary central nervous system angiitis: good diagnostic accuracy and high safety.
    J Neurol. 2021;268:367-376.
    PubMed         Abstract available
    
    
29. LLORENTE AYUSO L, Torres Rubio P, Beijinho do Rosario RF, Giganto Arroyo ML, et al
    Bickerstaff encephalitis after COVID-19.
    J Neurol. 2021;268:2035-2037.
    PubMed        
    
    
30. MATHIS S, Soulages A, Le Masson G, Vallat JM, et al
    Epidemics and outbreaks of peripheral nervous system disorders: I. infectious and immune-mediated causes.
    J Neurol. 2021;268:879-890.
    PubMed         Abstract available
    
    
31. BERGMAN J, Burman J, Bergenheim T, Svenningsson A, et al
    Intrathecal treatment trial of rituximab in progressive MS: results after a 2-year extension.
    J Neurol. 2021;268:651-657.
    PubMed         Abstract available
    
    
32. THOUIN A, Gastaldi M, Woodhall M, Jacobson L, et al
    Comparison of N-methyl-D-aspartate receptor antibody assays using live or fixed substrates.
    J Neurol. 2021;268:1818-1826.
    PubMed         Abstract available
    
    
33. DAO LM, Machule ML, Bacher P, Hoffmann J, et al
    Decreased inflammatory cytokine production of antigen-specific CD4(+) T cells in NMDA receptor encephalitis.
    J Neurol. 2021;268:2123-2131.
    PubMed         Abstract available
    
    
34. NIESSEN A, Schwarz B, Urban M, Kramer S, et al
    Aseptic meningitis after glatiramer acetate.
    J Neurol. 2021;268:2589-2590.
    PubMed        
    
    
35. KIM SH, Baek SH, Lee SU, Yu S, et al
    Optic disc edema as a sole manifestation of anti-GQ1b antibody syndrome.
    J Neurol. 2021;268:2263-2266.
    PubMed        
    
    
36. URBAIN F, Puyade M, Labeyrie C, Maubeuge N, et al
    Hematopoietic stem cell transplantation in chronic inflammatory demyelinating polyneuropathy: French experience about four patients, under the behalf of French society for bone marrow transplantation.
    J Neurol. 2021;268:1536-1539.
    PubMed        
    
    
37. KAPOOR M, Keh R, Compton L, Morrow S, et al
    Subcutaneous immunoglobulin dose titration to clinical response in inflammatory neuropathy.
    J Neurol. 2021;268:1485-1490.
    PubMed         Abstract available
    
    
38. YOO JS, Kim YS, Kim HY, Kwon HS, et al
    Comparison of patients with transient and sustained increments of antiphospholipid antibodies after acute ischemic stroke.
    J Neurol. 2021 Feb 6. pii: 10.1007/s00415-021-10432.
    PubMed         Abstract available
    
    
39. STARMANS NLP, van Dijk MR, Kappelle LJ, Frijns CJM, et al
    Sneddon syndrome: a comprehensive clinical review of 53 patients.
    J Neurol. 2021;268:2450-2457.
    PubMed         Abstract available
    
    

    
    J Pediatr Endocrinol Metab

40. BADRINATH MURTHY D, Gutierrez Alvarez A, Vargas W, Litao MKS, et al
    Auto-destruction of the thyroid gland and coexisting glutamic acid decarboxylase mediated neurological disease in an adolescent: an unusual presentation of autoimmunity.
    J Pediatr Endocrinol Metab. 2021 Jun 24. pii: jpem-2020-0697.
    PubMed         Abstract available
    
    

    
    Kidney Int

41. TURNER MP, Storey BC, Mittal S, Macanovic J, et al
    Candida crescents in a renal allograft.
    Kidney Int. 2020;98:1356.
    PubMed        
    
    
42. SCHENA FP, Anelli VW, Trotta J, Di Noia T, et al
    Development and testing of an artificial intelligence tool for predicting end stage kidney disease in patients with immunoglobulin A nephropathy.
    Kidney Int. 2020 Sep 1. pii: S0085-2538(20)30969.
    PubMed         Abstract available
    
    
43. KUDOSE S, Santoriello D, Debiec H, Canetta PA, et al
    The clinicopathologic spectrum of segmental membranous glomerulopathy.
    Kidney Int. 2021;99:247-255.
    PubMed         Abstract available
    
    
44. VAN BOMMEL EJM, Lytvyn Y, Perkins BA, Soleymanlou N, et al
    Renal hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in hyperfiltering people with type 1 diabetes and people with type 2 diabetes and normal kidney function.
    Kidney Int. 2020;97:631-635.
    PubMed        
    
    
45. RABANT M, Dessaix K, Buob D, Fagniez O, et al
    The Case | Membranous nephropathy after alemtuzumab treatment.
    Kidney Int. 2021;100:249-250.
    PubMed        
    
    
46. BERCHTOLD L, Letouze E, Alexander MP, Canaud G, et al
    Corrigendum to Berchtold L, Letouze E, Alexander MP, et al. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients. Kidney Int. 2021;99:671-685.
    Kidney Int. 2021;100:243.
    PubMed        
    
    
47. KUDOSE S, Friedman P, Albajrami O, D'Agati VD, et al
    Histologic correlates of gross hematuria following Moderna COVID-19 vaccine in patients with IgA nephropathy.
    Kidney Int. 2021 Jun 17. pii: S0085-2538(21)00598.
    PubMed        
    
    
48. RONCO P, Rovin B, Nangaku M, Wyatt C, et al
    Milestones in nephrology and welcoming the future: the 61st anniversary of the International Society of Nephrology.
    Kidney Int. 2021;99:2-4.
    PubMed        
    
    
49. FARRAH TE, Dhaun N
    Antineutrophil cytoplasm antibody positivity, kidney impairment, and cholesterol embolization.
    Kidney Int. 2021;99:774.
    PubMed        
    
    
50. NANGAKU M, Fogo AB
    Does a preclinical randomized controlled trial, pRCT, resolve the gap between animal studies and human trials?
    Kidney Int. 2021;99:1262-1264.
    PubMed         Abstract available
    
    

    
    Lancet Neurol

51. SUZUKI S
    Targeted molecular therapy for myasthenia gravis.
    Lancet Neurol. 2021;20:499-500.
    PubMed        
    
    
52. WATTJES MP, Ciccarelli O, Reich DS, Banwell B, et al
    2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis.
    Lancet Neurol. 2021 Jun 14. pii: S1474-4422(21)00095.
    PubMed         Abstract available
    
    
53. THE LANCET NEUROLOGY
    Multiple sclerosis under the spotlight.
    Lancet Neurol. 2021;20:497.
    PubMed        
    
    
54. HOWARD JF JR, Bril V, Vu T, Karam C, et al
    Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial.
    Lancet Neurol. 2021;20:526-536.
    PubMed         Abstract available
    
    
55. WIJERATNE T, Grisold W, Baneke P, Helme A, et al
    World Brain Day 2021: a call to stop multiple sclerosis.
    Lancet Neurol. 2021 Jun 21. pii: S1474-4422(21)00200.
    PubMed        
    
    

    
    Mult Scler

56. SCHONFELDER K, Schuh H, Pfister F, Kramer J, et al
    Autoimmune glomerulonephritis in a multiple sclerosis patient after cladribine treatment.
    Mult Scler. 2021 Jun 24:13524585211022719. doi: 10.1177/13524585211022719.
    PubMed         Abstract available
    
    
57. ESHAGHI A
    Towards an objective classification of multiple sclerosis.
    Mult Scler. 2021;27:1151-1152.
    PubMed        
    
    

    
    N Engl J Med

58. O'CONNELL KA, LaChance AH
    Dermatomyositis.
    N Engl J Med. 2021;384:2437.
    PubMed        
    
    

    
    Nat Rev Neurol

59. MAKHANI N, Tremlett H
    The multiple sclerosis prodrome.
    Nat Rev Neurol. 2021 Jun 21. pii: 10.1038/s41582-021-00519.
    PubMed         Abstract available
    
    

    
    PLoS One

60. SUBEKTI I, Kartiko GJ, Suhardi ZF, Muhadi, et al
    Serum TSH level as predictor of Graves' disease recurrence following antithyroid drug withdrawal: A systematic review.
    PLoS One. 2021;16:e0245978.
    PubMed         Abstract available
    
    
61. HASEGAWA M, Iwasaki J, Sugiyama S, Ishihara T, et al
    Development of aortic valve stenosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis with renal involvement.
    PLoS One. 2021;16:e0245869.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

62. MITCHELL AM, Alkanani AA, McDaniel KA, Pyle L, et al
    T-cell responses to hybrid insulin peptides prior to type 1 diabetes development.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available
    
    
63. MUNOZ M, Hegazy AN, Brunner TM, Holecska V, et al
    Th2 cells lacking T-bet suppress naive and memory T cell responses via IL-10.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: